Darmstadt, Germany

Claudio Mattina

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Exocad Gmbh. Active years: 2025.


% Patents Active = 100.0


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Claudio Mattina in Dental Prosthetics

Introduction

Claudio Mattina is an innovative inventor based in Darmstadt, Germany. He has made significant contributions to the field of dental prosthetics, particularly with his unique inventions aimed at improving the quality and efficiency of dental procedures.

Latest Patents

One of Claudio Mattina's notable patents is a bonding auxiliary device for artificial teeth. This invention relates to a device designed for arranging, aligning, and fixing multiple artificial teeth into an artificial gingiva of a dental prosthesis. The bonding auxiliary device includes an occlusion device for arranging and aligning the teeth relative to one another, a support device for supporting a prosthetic body of the first dental prosthesis comprising the gingiva, and a clamping element for fixing the teeth, which are arranged and aligned by means of the occlusion device, in the gingiva supported by the support device. This patent showcases his commitment to enhancing dental technology and patient care.

Career Highlights

Claudio Mattina is currently associated with Exocad GmbH, a company known for its innovative solutions in dental CAD/CAM software. His work at Exocad reflects his dedication to advancing dental technology and improving the tools available to dental professionals.

Collaborations

Due to space constraints, details about collaborations will not be included.

Conclusion

Claudio Mattina's contributions to dental prosthetics through his innovative patent demonstrate his expertise and commitment to improving dental care. His work continues to influence the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…